shutterstock_1639774756_poptika
Poptika / Shutterstock.com
24 May 2022GeneticsMuireann Bolger

OptraHealth sues Invitae over genetic testing chatbot

OptraHealth has filed a patent infringement lawsuit against Invitae that centres on the latter’s Gia chatbot that offers genetic testing and advice.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
13 May 2021   Generics manufacturer Invitae has filed a lawsuit against rival company Natera claiming that its cancer detection test infringes one of Invitae’s DNA sequencing patents.
Genetics
6 May 2021   The World Intellectual Property Office has launched a course on IP and genetic resources in the life sciences.

More on this story

Big Pharma
13 May 2021   Generics manufacturer Invitae has filed a lawsuit against rival company Natera claiming that its cancer detection test infringes one of Invitae’s DNA sequencing patents.
Genetics
6 May 2021   The World Intellectual Property Office has launched a course on IP and genetic resources in the life sciences.

More on this story

Big Pharma
13 May 2021   Generics manufacturer Invitae has filed a lawsuit against rival company Natera claiming that its cancer detection test infringes one of Invitae’s DNA sequencing patents.
Genetics
6 May 2021   The World Intellectual Property Office has launched a course on IP and genetic resources in the life sciences.